ArticlePharmacoEconomics2021

Cost-of-Illness Progression Before and After Diagnosis of Multiple Sclerosis: A Nationwide Register-Based Cohort Study in Sweden of People Newly Diagnosed with Multiple Sclerosis and a Population-Based Matched Reference Group.

Chantelle Murley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.